SCHEMBL30648788

SCHEMBL30648788

Cc1c(Br)cnc2c1NCC2(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30648675 0.69 — —
SCHEMBL22695582 0.68 MAP4K1 (0.41) —
SCHEMBL29422873 0.68 MAP4K1 (0.41) —
SCHEMBL22884709 0.68 MAP4K1 (0.38) —
SCHEMBL1368910 0.66 NNMT (0.35) —
SCHEMBL23771331 0.65 MAP4K1 (0.37) —
SCHEMBL23790564 0.64 MAP4K1 (0.40) —
SCHEMBL12146400 0.63 AKT1S1 (0.31) —
SCHEMBL29516134 0.62 AKR1B1 (0.33) —
SCHEMBL21828348 0.62 MAP4K1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522618-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES COMPOUNDS AS HPK1 INHIBITORS Merck Patent GmbH (DE) 2025-03-19 — — EP disclosed
WO-2023220541-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES COMPOUNDS AS HPK1 INHIBITORS MERCK PATENT GMBH (DE) 2023-11-16 — — WO disclosed
Send feedback